IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q4 2024 Holdings

Filed 2025-02-13 | 11 holdings | $148.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vaxcyte Inc(PCVX)COM92243G108$57.6M703,83438.9%
Oculis Holding AG(OCS)ORDINARY SHARESH5870P102$29.5M1,737,69620.0%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$29.5M2,120,50819.9%
Inozyme Pharma IncCOM45790W108$12.5M4,494,8518.4%
Zenas Biopharma Inc(ZBIO)COM98937L105$6.0M736,6454.1%
Recursion Pharmaceuticals in(RXRX)CL A75629V104$4.0M595,5182.7%
Bioage Labs Inc(BIOA)COM09077V100$3.8M653,3742.6%
Rallybio CorpCOM75120L100$2.3M2,404,6441.6%
Bolt Biotherapeutics Inc(BOLT1EUR)COM097702104$1.0M1,891,4670.7%
Vigil Neuroscience Inc(VIGL)COM92673K108$953.0K560,5950.6%
IO Biotech Inc(IOBT)COM449778109$795.1K864,1970.5%